Rachel Lane, PhD is the Director, Business Development at Ovid. Previously, Rachel was in Equity Research for Wainwright which she joined after her position as Assistant Director, Scientific Affairs at the Alzheimer’s Drug Discovery Foundation (ADDF). At the ADDF, Dr. Lane managed the Foundation’s drug discovery grants program and the strategic development of resources and public private partnerships. Prior to joining the ADDF, Dr. Lane earned her Ph.D in Molecular Biology and Biotechnology from the University of Sheffield, UK before undertaking her postdoctoral research on Alzheimer’s disease in a team led by Dr. Sam Gandy.